Neuroone Medical Technologies (NMTC) Other Gross PP&E Adjustments (2018 - 2026)
Neuroone Medical Technologies (NMTC) reported Other Gross PP&E Adjustments of -$489089.0 for Q1 2026, down 56.93% on a YoY basis from -$1.1 million in Q1 2025, and down 35.3% quarter-over-quarter from -$361495.0 in Q4 2025.
Neuroone Medical Technologies (NMTC) Other Gross PP&E Adjustments (2018 - 2026) Analysis & Trends
Neuroone Medical Technologies has reported Other Gross PP&E Adjustments for 9 years, with the latest figure at -$489089.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments fell 56.93% year-over-year to -$489089.0; the trailing twelve-month figure through Mar 2026 stood at -$489089.0 (down 56.93% YoY), and the FY2025 full-year result was -$385295.0, down 198.76% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$489089.0, down from -$361495.0 in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $1.9 billion in Q3 2022, with the low at -$489089.0 in Q1 2026.
- Historically, Other Gross PP&E Adjustments has averaged $111.4 million across 5 years, with a median of -$169059.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Gross PP&E Adjustments soared 443514.98% — and 2025, when it plunged 198.76%.
- Neuroone Medical Technologies' Other Gross PP&E Adjustments stood at $297454.0 in 2022, then tumbled by 147.13% to -$140198.0 in 2023, then surged by 546.74% to $626326.0 in 2024, then tumbled by 157.72% to -$361495.0 in 2025, then tumbled by 35.3% to -$489089.0 in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$489089.0 (Q1 2026), -$361495.0 (Q4 2025), and -$385295.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 23.14 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -405.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -547.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -99.30 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 5.30 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 2.39 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 991.00 Mn |
| 10 | Neuroone Medical Technologies | 27.15 Mn | 24.35 Mn | 1.29 Mn | -489,089.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -489,089.00 |
| Mar 31, 2026 | -489,089.00 |
| Dec 31, 2025 | -361,495.00 |
| Dec 31, 2025 | -361,495.00 |
| Sep 30, 2025 | -385,295.00 |
| Sep 30, 2025 | -385,295.00 |
| Jun 30, 2025 | -283,621.00 |
| Jun 30, 2025 | -283,621.00 |
| Mar 31, 2025 | -311,652.00 |
| Mar 31, 2025 | -311,652.00 |
| Dec 31, 2024 | 626,326.00 |
| Dec 31, 2024 | 626,326.00 |
| Sep 30, 2024 | 390,116.00 |
| Sep 30, 2024 | 390,116.00 |
| Jun 30, 2024 | -281,833.00 |
| Jun 30, 2024 | -281,833.00 |
| Mar 31, 2024 | -110,724.00 |
| Mar 31, 2024 | -110,724.00 |
| Dec 31, 2023 | -140,198.00 |
| Dec 31, 2023 | -140,198.00 |